Surgalign Receives FDA Clearance For HOLO Portal System, The World's First AI-driven AR Guidance System For Spine Surgery
Surgalign Receives FDA Clearance For HOLO Portal System, The World's First AI-driven AR Guidance System For Spine Surgery
Surgalign 获得 FDA 批准 HOLO Portal System，这是世界上第一个用于脊柱外科的人工智能驱动的 AR 引导系统
Surgalign Holdings, Inc., (NASDAQ:SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced that it has received U.S. Food & Drug Administration (FDA) 510(k) clearance for its HOLO Portal surgical guidance system for use within lumbar spine procedures. The HOLO Portal system is the world's first artificial intelligence (AI)-driven augmented reality (AR) guidance system for spine and the first clinical application of Surgalign's HOLOTM AI digital health platform.
Surgalign Holdings，Inc.(纳斯达克代码：SRGA)是一家专注于通过推动数字健康演进来提升护理标准的全球医疗技术公司，该公司今天宣布，其用于腰椎手术的Holo门户手术导航系统已获得美国食品和药物管理局510(K)批准。Holo门户系统是世界上第一个由人工智能(AI)驱动的增强现实(AR)脊柱引导系统，也是Surgalign的HOLOTM-AI数字健康平台的首次临床应用。
"Receiving the initial clearance for the HOLO Portal system is a significant milestone and represents...
Surgalign首席执行官兼...
登录免费看全文
登录/注册
资讯热榜
更新时间